Evidence map›Paper›PMID 22671779›Full record

ArticleBritish journal of pharmacology2012

The anti-nausea effects of CB1 agonists are mediated by an action at the visceral insular cortex.

C L Limebeer, E M Rock, R Mechoulam, L A Parker

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Endocannabinoid signaling in stress, nausea, and vomiting.Neurogastroenterology and motility · 2025
    Review
  3. Article
  4. Article
  5. Cannabinoids: Therapeutic Use in Clinical Practice.International journal of molecular sciences · 2022
    Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Central Aspects of Nausea and Vomiting in GI Disorders.Current treatment options in gastroenterology · 2016
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Cannabinoid Regulation of Acute and Anticipatory Nausea.Cannabis and cannabinoid research · 2016
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

C L LimebeerDepartment of Psychology and Neuroscience Graduate Program, University of Guelph, Guelph, Ontario, Canada.
E M Rock
R Mechoulam
L A Parker
University of Guelph · CAHebrew University of Jerusalem · IL

Funding

SYNTHESIS OF SR141716A AND ANANDAMIDE ANALOGSP01DA009789 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI CRAVATT, BENJAMIN F · 1995 to 2013
$11.6M
NIDA NIH HHS P01 DA009789
6 · The paper itself

Abstract

background and purposeConditioned gaping reactions reflect nausea-induced behaviour in rats. Cannabinoid 1 receptor (CB(1) ) agonists interfere with the establishment of nausea-induced conditioned gaping; however, it is not known if their effects are mediated by an action at peripheral or central CB(1) receptors. EXPERIMENTAL APPROACH: We utilized the conditioned gaping model of nausea to evaluate the effect of peripheral and central administration of the peripherally restricted CB(1) agonist, CB13, on the establishment of LiCl-induced gaping in rats. We further evaluated the ability of HU-210 administered to the gustatory insular cortex (GIC) or visceral insular cortex (VIC) to interfere with LiCl-induced conditioned gaping and determined if this effect was mediated by CB(1) receptors. KEY

resultsCentral, but not peripheral, CB13 suppressed LiCl-induced conditioned gaping. Central administration of the potent CB(1) agonist, HU-210, delivered to the VIC, but not the GIC, suppressed the establishment of LiCl-induced gaping reactions, but not LiCl-induced suppression of hedonic reactions or conditioned taste avoidance. This pattern of results suggests that HU-210 delivered to the VIC prevented LiCl-induced nausea, but not learning per se. The suppression of LiCl-induced conditioned gaping by HU-210 was mediated by CB(1) receptors because it was prevented by co-administration of CB(1) antagonist/inverse agonist, AM-251, into the VIC. A high dose of AM-251 (20 µg) administered alone into the VIC did not produce conditioned gaping reactions. CONCLUSIONS AND IMPLICATIONS: The nausea-relieving effects of CB(1) agonists, but not the nausea-inducing effects of CB(1) inverse agonists, are mediated, at least in part, by their action at the VIC in rats.

Indexed as

AnimalsAntiemeticsCannabinoid Receptor AgonistsCannabinoid Receptor AntagonistsCerebral CortexDronabinolLithium ChlorideMaleNaphthalenesNauseaPiperidinesPyrazolesRatsRats, Sprague-DawleyReceptor, Cannabinoid, CB1AM 251AntiemeticsCannabinoid Receptor AgonistsCannabinoid Receptor AntagonistsDronabinolHU 211Lithium Chloridenaphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanoneNaphthalenesPiperidinesPyrazolesReceptor, Cannabinoid, CB1

Identifiers

PMID22671779
PMCPMC3492992
OpenAlexW2130960518

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.